Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation
NCT: NCT05696860 · COMPLETED
Brief Summary
Purpose: Researchers wanted to investigate the effect of capnography monitoring in addition to routine monitoring on the development of desaturation and other vital parameters in endobronchial ultrasonography (EBUS) cases. Method: 100 patients who underwent EBUS under sedation will be included in this prospective and randomized controlled study. The cases will be divided into two groups of 50 people each. In the first group, standard monitoring will be performed, and in the second group, in addition to standard monitoring, capnography monitoring will be used. Heart rate, blood pressure, peripheral oxygen saturation (SpO2) values in both groups, end-tidal carbon dioxide (EtCO2), respiratory rate and integrated pulmonary index (IPI) values in the second group will be recorded in all cases. Disturbances in vital parameters and airway interventions, which were common in both groups, will ve compared. The frequency of problems detected by capnography monitoring in the second group will be examined.
Frequently Asked Questions
What is Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation?
Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation is a clinical trial registered under NCT05696860. Current status: COMPLETED.
What is the status of NCT05696860?
The current status of NCT05696860 (Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation) is: COMPLETED.
When did Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation start?
Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation started on 2019-04-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.